{"id":840255,"date":"2022-12-05T18:00:27","date_gmt":"2022-12-05T17:00:27","guid":{"rendered":"https:\/\/bebeez.it\/non-categorizzato\/vaxxas-raises-us23-million-a34-million-to-clinically-advance-needle-free-vaccines-including-a-next-generation-covid-19-vaccine-candidate\/"},"modified":"2022-12-05T18:00:27","modified_gmt":"2022-12-05T17:00:27","slug":"vaxxas-raises-us23-million-a34-million-to-clinically-advance-needle-free-vaccines-including-a-next-generation-covid-19-vaccine-candidate","status":"publish","type":"post","link":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/vaxxas-raises-us23-million-a34-million-to-clinically-advance-needle-free-vaccines-including-a-next-generation-covid-19-vaccine-candidate\/","title":{"rendered":"Vaxxas Raises US$23 million (A$34 million) to Clinically Advance Needle-Free Vaccines, Including a Next-Generation COVID-19 Vaccine Candidate"},"content":{"rendered":"Vaxxas to progress multiple vaccine programs in the clinic and ramp up manufacturing capabilities toward commercial scale.\nEquity funding to leverage non-dilutive financial support of more than US$67 million (A$100 million) which has been provided and committed under contracts with US and Australian government agencies, industry collaborators, and global health organizations.\nInvestment round led by OneVentures and UniQuest Pty Ltd, including support from existing and new investors, in addition to Vaxxas BoD and management.\nCAMBRIDGE, Mass. & BRISBANE, Australia--(BUSINESS WIRE)--Vaxxas, a clinical-stage biotechnology company commercializing a novel vaccination platform, today announced it has completed a financing round which raised US
Abbonati<\/a> o Accedi<\/a> per leggere il resto di questo contenuto.<\/div><\/div>","protected":false},"excerpt":{"rendered":"

Vaxxas to progress multiple vaccine programs in the clinic and ramp up manufacturing capabilities toward commercial scale. Equity funding to leverage non-dilutive financial support of more than US$67 million (A$100 million) which has been provided and committed under contracts with US and Australian government agencies, industry collaborators, and global health organizations. Investment round led by […]<\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[49625],"tags":[],"settori":[],"slider_categorie_and_home_page":[],"class_list":["post-840255","post","type-post","status-publish","format-standard","hentry","category-private-capital-in-north-america"],"acf":[],"yoast_head":"\nVaxxas Raises US$23 million (A$34 million) to Clinically Advance Needle-Free Vaccines, Including a Next-Generation COVID-19 Vaccine Candidate - BeBeez<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/vaxxas-raises-us23-million-a34-million-to-clinically-advance-needle-free-vaccines-including-a-next-generation-covid-19-vaccine-candidate\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Vaxxas Raises US$23 million (A$34 million) to Clinically Advance Needle-Free Vaccines, Including a Next-Generation COVID-19 Vaccine Candidate - BeBeez\" \/>\n<meta property=\"og:description\" content=\"Vaxxas to progress multiple vaccine programs in the clinic and ramp up manufacturing capabilities toward commercial scale. Equity funding to leverage non-dilutive financial support of more than US$67 million (A$100 million) which has been provided and committed under contracts with US and Australian government agencies, industry collaborators, and global health organizations. Investment round led by […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/vaxxas-raises-us23-million-a34-million-to-clinically-advance-needle-free-vaccines-including-a-next-generation-covid-19-vaccine-candidate\/\" \/>\n<meta property=\"og:site_name\" content=\"BeBeez\" \/>\n<meta property=\"article:published_time\" content=\"2022-12-05T17:00:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo-x2.png\" \/>\n\t<meta property=\"og:image:width\" content=\"683\" \/>\n\t<meta property=\"og:image:height\" content=\"242\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/vaxxas-raises-us23-million-a34-million-to-clinically-advance-needle-free-vaccines-including-a-next-generation-covid-19-vaccine-candidate\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/vaxxas-raises-us23-million-a34-million-to-clinically-advance-needle-free-vaccines-including-a-next-generation-covid-19-vaccine-candidate\/\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"Vaxxas Raises US$23 million (A$34 million) to Clinically Advance Needle-Free Vaccines, Including a Next-Generation COVID-19 Vaccine Candidate\",\"datePublished\":\"2022-12-05T17:00:27+00:00\",\"dateModified\":\"2022-12-05T17:00:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/vaxxas-raises-us23-million-a34-million-to-clinically-advance-needle-free-vaccines-including-a-next-generation-covid-19-vaccine-candidate\/\"},\"wordCount\":771,\"publisher\":{\"@id\":\"https:\/\/15.161.165.86\/#organization\"},\"articleSection\":[\"Private capital in North America\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/vaxxas-raises-us23-million-a34-million-to-clinically-advance-needle-free-vaccines-including-a-next-generation-covid-19-vaccine-candidate\/\",\"url\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/vaxxas-raises-us23-million-a34-million-to-clinically-advance-needle-free-vaccines-including-a-next-generation-covid-19-vaccine-candidate\/\",\"name\":\"Vaxxas Raises US$23 million (A$34 million) to Clinically Advance Needle-Free Vaccines, Including a Next-Generation COVID-19 Vaccine Candidate - BeBeez\",\"isPartOf\":{\"@id\":\"https:\/\/15.161.165.86\/#website\"},\"datePublished\":\"2022-12-05T17:00:27+00:00\",\"dateModified\":\"2022-12-05T17:00:27+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/vaxxas-raises-us23-million-a34-million-to-clinically-advance-needle-free-vaccines-including-a-next-generation-covid-19-vaccine-candidate\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/vaxxas-raises-us23-million-a34-million-to-clinically-advance-needle-free-vaccines-including-a-next-generation-covid-19-vaccine-candidate\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/vaxxas-raises-us23-million-a34-million-to-clinically-advance-needle-free-vaccines-including-a-next-generation-covid-19-vaccine-candidate\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/bebeez.it\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Vaxxas Raises US$23 million (A$34 million) to Clinically Advance Needle-Free Vaccines, Including a Next-Generation COVID-19 Vaccine Candidate\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/15.161.165.86\/#website\",\"url\":\"https:\/\/15.161.165.86\/\",\"name\":\"BeBeez\",\"description\":\"BeBeez\",\"publisher\":{\"@id\":\"https:\/\/15.161.165.86\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/15.161.165.86\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/15.161.165.86\/#organization\",\"name\":\"BeBeez\",\"url\":\"https:\/\/15.161.165.86\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png\",\"contentUrl\":\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png\",\"width\":309,\"height\":122,\"caption\":\"BeBeez\"},\"image\":{\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Vaxxas Raises US$23 million (A$34 million) to Clinically Advance Needle-Free Vaccines, Including a Next-Generation COVID-19 Vaccine Candidate - BeBeez","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/vaxxas-raises-us23-million-a34-million-to-clinically-advance-needle-free-vaccines-including-a-next-generation-covid-19-vaccine-candidate\/","og_locale":"en_US","og_type":"article","og_title":"Vaxxas Raises US$23 million (A$34 million) to Clinically Advance Needle-Free Vaccines, Including a Next-Generation COVID-19 Vaccine Candidate - BeBeez","og_description":"Vaxxas to progress multiple vaccine programs in the clinic and ramp up manufacturing capabilities toward commercial scale. Equity funding to leverage non-dilutive financial support of more than US$67 million (A$100 million) which has been provided and committed under contracts with US and Australian government agencies, industry collaborators, and global health organizations. Investment round led by […]","og_url":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/vaxxas-raises-us23-million-a34-million-to-clinically-advance-needle-free-vaccines-including-a-next-generation-covid-19-vaccine-candidate\/","og_site_name":"BeBeez","article_published_time":"2022-12-05T17:00:27+00:00","og_image":[{"width":683,"height":242,"url":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo-x2.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/vaxxas-raises-us23-million-a34-million-to-clinically-advance-needle-free-vaccines-including-a-next-generation-covid-19-vaccine-candidate\/#article","isPartOf":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/vaxxas-raises-us23-million-a34-million-to-clinically-advance-needle-free-vaccines-including-a-next-generation-covid-19-vaccine-candidate\/"},"author":{"name":"","@id":""},"headline":"Vaxxas Raises US$23 million (A$34 million) to Clinically Advance Needle-Free Vaccines, Including a Next-Generation COVID-19 Vaccine Candidate","datePublished":"2022-12-05T17:00:27+00:00","dateModified":"2022-12-05T17:00:27+00:00","mainEntityOfPage":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/vaxxas-raises-us23-million-a34-million-to-clinically-advance-needle-free-vaccines-including-a-next-generation-covid-19-vaccine-candidate\/"},"wordCount":771,"publisher":{"@id":"https:\/\/15.161.165.86\/#organization"},"articleSection":["Private capital in North America"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/vaxxas-raises-us23-million-a34-million-to-clinically-advance-needle-free-vaccines-including-a-next-generation-covid-19-vaccine-candidate\/","url":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/vaxxas-raises-us23-million-a34-million-to-clinically-advance-needle-free-vaccines-including-a-next-generation-covid-19-vaccine-candidate\/","name":"Vaxxas Raises US$23 million (A$34 million) to Clinically Advance Needle-Free Vaccines, Including a Next-Generation COVID-19 Vaccine Candidate - BeBeez","isPartOf":{"@id":"https:\/\/15.161.165.86\/#website"},"datePublished":"2022-12-05T17:00:27+00:00","dateModified":"2022-12-05T17:00:27+00:00","breadcrumb":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/vaxxas-raises-us23-million-a34-million-to-clinically-advance-needle-free-vaccines-including-a-next-generation-covid-19-vaccine-candidate\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/bebeez.it\/en\/private-capital-in-north-america\/vaxxas-raises-us23-million-a34-million-to-clinically-advance-needle-free-vaccines-including-a-next-generation-covid-19-vaccine-candidate\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/vaxxas-raises-us23-million-a34-million-to-clinically-advance-needle-free-vaccines-including-a-next-generation-covid-19-vaccine-candidate\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/bebeez.it\/en\/"},{"@type":"ListItem","position":2,"name":"Vaxxas Raises US$23 million (A$34 million) to Clinically Advance Needle-Free Vaccines, Including a Next-Generation COVID-19 Vaccine Candidate"}]},{"@type":"WebSite","@id":"https:\/\/15.161.165.86\/#website","url":"https:\/\/15.161.165.86\/","name":"BeBeez","description":"BeBeez","publisher":{"@id":"https:\/\/15.161.165.86\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/15.161.165.86\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/15.161.165.86\/#organization","name":"BeBeez","url":"https:\/\/15.161.165.86\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/","url":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png","contentUrl":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png","width":309,"height":122,"caption":"BeBeez"},"image":{"@id":"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts\/840255","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/comments?post=840255"}],"version-history":[{"count":0,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts\/840255\/revisions"}],"wp:attachment":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/media?parent=840255"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/categories?post=840255"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/tags?post=840255"},{"taxonomy":"settori","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/settori?post=840255"},{"taxonomy":"slider_categorie_and_home_page","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/slider_categorie_and_home_page?post=840255"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}